Clinical trial Recruiting at 1 site Interventional Ages 60 to 75

Plant versus animal protein supplements to improve brain blood flow, insulin response, thinking, and appetite in older adults

Official title: Effects of Daily Protein Supplementation on Brain Function in Older Adults With Overweight or Obesity

Run by Maastricht University Medical Center · NCT07057245 · Data updated 2026-11-12

This tests whether two weeks of a daily plant or animal protein supplement can improve brain blood flow, brain insulin response, thinking, and appetite control in overweight or obese adults aged 60–75.

More Cognitive Function trials

Quick facts

Study typeInterventional
Ages60 Years to 75 Years
SexAll
Enrollment25 (estimated)
SponsorMaastricht University Medical Center
Academic / other
Locations1 site (Maastricht, Limburg)
StatusRecruiting
StartedJuly 2, 2025
Main results expectedDecember 31, 2025
Study endsDecember 31, 2025
Registry record updatedJuly 9, 2025
Trial IDNCT07057245 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are men and women aged 60–75 with BMI 25–35 kg/m2, stable body weight, normal fasting glucose and lipid thresholds, willing to attend in-person visits and avoid blood donation around the study period, and without diabetes, vegetarian diet, or relevant food allergies.

Probably not a fit

People with diabetes, vegetarians, those with milk or fava bean allergies, current smokers, or those outside the specified age and BMI ranges are unlikely to qualify or to receive benefit from the interventions tested here.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Overweight or obese adults aged 60–75 receive daily supplementation for two weeks with either a plant-derived protein isolate, an animal-derived protein isolate, or a cornstarch control, and undergo before-and-after testing. Key outcomes include measures of cerebral blood flow and brain insulin sensitivity, plus cognitive performance tests and appetite-related brain reward activity. Participants are screened to exclude diabetes, major metabolic abnormalities, vegetarians, and certain allergies, and testing is conducted at the Maastricht University Medical Center. The design aims to determine whether short-term protein supplementation from different sources produces measurable changes in brain vascular and metabolic function and related behaviors.

Why it matters

Potential benefit: If successful, the intervention could show that short-term protein supplementation—especially from sustainable plant sources—improves brain blood flow, insulin response, thinking, and appetite control in overweight older adults.

How similar studies have gone: Some prior work suggests protein-rich meals can improve brain insulin sensitivity and appetite regulation, but direct head-to-head comparisons of plant versus animal protein on brain vascular function remain limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Men and women, aged between 60-75 years (older adults)
* BMI between 25-35 kg/m2 (overweight or obese)
* Fasting plasma glucose \< 7.0 mmol/L
* Fasting serum total cholesterol \< 8.0 mmol/L
* Fasting serum triacylglycerol \< 4.5 mmol/L
* Systolic blood pressure \< 160 mmHg and diastolic blood pressure \< 100 mmHg
* Stable body weight (weight gain or loss \< 3 kg in the past three months)
* Willingness to give up being a blood donor from 8 weeks before the start of the study, during the study and for 4 weeks after completion of the study
* No difficult venipuncture as evidenced during the screening visit

Exclusion Criteria:

* Intolerant to milk products or fava bean allergy
* Vegetarians
* Left-handedness
* Current smoker, or smoking cessation \< 12 months
* Diabetic patients
* Familial hypercholesterolemia
* Abuse of drugs
* More than 3 alcoholic consumptions per day
* Use of products or dietary supplements known to interfere with the main outcomes as judged by the principal investigators
* Use medication to treat blood pressure, lipid, or glucose metabolism
* Use of an investigational product within another biomedical intervention trial within the previous 1-month
* Severe medical conditions that might interfere with the study, such as epilepsy, asthma, kidney failure or renal insufficiency, chronic obstructive pulmonary disease, inflammatory bowel diseases, auto inflammatory diseases, and rheumatoid arthritis
* Active cardiovascular disease like congestive heart failure or cardiovascular event, such as an acute myocardial infarction or cerebrovascular accident
* Contra-indications for MRI imaging (e.g., pacemaker, surgical clips/material in body, metal splinter in eye, claustrophobia)

Where it's running

  • Maastricht University Medical Center
    Maastricht, Limburg, Netherlands
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.